Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide.

MLA

Abate, Marianna, et al. “Self-Assembling Nanoparticles for Delivery of MiR-603 and MiR-221 in Glioblastoma as a New Strategy to Overcome Resistance to Temozolomide.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 377, Nov. 2024, pp. 458–69. EBSCOhost, https://doi.org/10.1016/j.jconrel.2024.11.039.

APA

Abate, M., Porru, M., Campani, V., Leonetti, C., Nele, V., Di Paola, R., De Martino, M., Russo, M., Tathode, M., Cossu, A. M., Bocchetti, M., Angelillo, A., Ianniello, M., Petrillo, N., Savarese, G., Monica, R. D., Chiariotti, L., Addeo, R., Caraglia, M., … Zappavigna, S. (2024). Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide. Journal of Controlled Release : Official Journal of the Controlled Release Society, 377, 458–469. https://doi.org/10.1016/j.jconrel.2024.11.039

Chicago

Abate, Marianna, Manuela Porru, Virginia Campani, Carlo Leonetti, Valeria Nele, Rossella Di Paola, Marco De Martino, et al. 2024. “Self-Assembling Nanoparticles for Delivery of MiR-603 and MiR-221 in Glioblastoma as a New Strategy to Overcome Resistance to Temozolomide.” Journal of Controlled Release : Official Journal of the Controlled Release Society 377 (November): 458–69. doi:10.1016/j.jconrel.2024.11.039.